ArticleArthritis research & therapy2020

Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort.

Stéphanie Dierckx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.